Casandra
Casandra Test Code PR83327Version 1 (DRAFT)
Performing Lab
Lab Prometheus LaboratoriesLab Test ID #3140
Anser RZB
Clinical Use
Order TestUse
The Anser RZB test is designed for monitoring risankizumab (RZB) and antibodies-to-RZB (ATR) levels. This test helps in achieving optimal therapeutic responses by guiding dosage adjustments based on serum drug concentrations.
Special Instructions
Not provided.
Limitations
Anser RZB is a laboratory-developed test which has not been approved by the FDA. It follows CLIA guidelines for its clinical and analytical validation but does not have WHO standards due to the nature of RZB.
Test Details
Methodology
Immunoassay (HMSA)
Biomarkers
Result Turnaround Time
3 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
2.0 mL
Minimum Volume
0.5 mL for Peds
Container
Serum Separator Tube or Red-Top Tube
Storage Instructions
Transport ambient or with a cold pack. Do not freeze.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
Similar Tests
Other tests from different labs that may be relevant
Ravulizumab, Serum
Mayo Clinic Lab
Certolizumab and Anti-Certolizumab Antibody, DoseASSURE CTZ
Mayo Clinic Lab
Rituximab and Anti-Rituximab Antibody, DoseASSURE™ RTX
Labcorp
Certolizumab and Anti-Certolizumab Antibody, DoseASSURE™ CTZ
Labcorp
Ravulizumab Monitoring Panel, Serum
Mayo Clinic Lab
Infliximab and Antibodies to Infliximab Quantitation
ARUP Laboratories
Ustekinumab Quantitation with Antibodies, Serum
ARUP Laboratories
Ustekinumab and Anti-Ustekinumab Antibody, DoseASSURE™ UST
Labcorp
Adalimumab Drug Level and Anti‑drug Antibody for Rheumatic Diseases
Quest Diagnostics
Adalimumab and Antibodies to Adalimumab Quantitation
ARUP Laboratories